Education
About Us
Working with TipRanks
Follow Us
Exact Sciences Corp. (EXAS)
NASDAQ:EXAS
Total Valuation
Exact Sciences has a market cap or net worth of $19.80B. The enterprise value is $21.30B.
Market Cap$19.80B
Enterprise Value$21.30B
Share Statistics
Exact Sciences has 190,888,210 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding190,888,210
Owned by Insiders1.20%
Owned by Institutions11.13%
Financial Efficiency
Exact Sciences’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -1.88%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-1.88%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee470.58K
Profits Per Employee-30.14K
Employee Count6,900
Asset Turnover0.55
Inventory Turnover5.92
Valuation Ratios
The current PE Ratio of Exact Sciences is ―. Exact Sciences’s PEG ratio is 1.15.
PE Ratio―
PS Ratio5.90
PB Ratio7.98
Price to Fair Value7.98
Price to FCF53.71
Price to Operating Cash Flow40.04
PEG Ratio1.15
Income Statement
In the last 12 months, Exact Sciences had revenue of 3.25B and earned -207.95M in profits. Earnings per share was -1.10.
Revenue3.25B
Gross Profit2.26B
Operating Income-99.08M
Pretax Income-203.89M
Net Income-207.95M
EBITDA122.50M
Earnings Per Share (EPS)-1.10
Cash Flow
In the last 12 months, operating cash flow was 491.44M and capital expenditures -134.66M, giving a free cash flow of 356.78M billion.
Operating Cash Flow491.44M
Free Cash Flow356.78M
Free Cash Flow per Share1.87
Dividends & Yields
Exact Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.12
52-Week Price Change126.00%
50-Day Moving Average102.65
200-Day Moving Average72.17
Relative Strength Index (RSI)70.51
Average Volume (3m)2.18M
Important Dates
Exact Sciences upcoming earnings date is May 13, 2026, After Close (Confirmed).
Last Earnings DateFeb 13, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Exact Sciences as a current ratio of 2.43, with Debt / Equity ratio of 105.07%
Current Ratio2.43
Quick Ratio2.17
Debt to Market Cap0.12
Net Debt to EBITDA12.79
Interest Coverage Ratio-3.01
Taxes
In the past 12 months, Exact Sciences has paid 4.06M in taxes.
Income Tax4.06M
Effective Tax Rate-0.02
Enterprise Valuation
Exact Sciences EV to EBITDA ratio is 169.22, with an EV/FCF ratio of 58.10.
EV to Sales6.38
EV to EBITDA169.22
EV to Free Cash Flow58.10
EV to Operating Cash Flow42.18
Balance Sheet
Exact Sciences has $964.71M in cash and marketable securities with $2.52B in debt, giving a net cash position of -$1.56B billion.
Cash & Marketable Securities$964.71M
Total Debt$2.52B
Net Cash-$1.56B
Net Cash Per Share-$8.16
Tangible Book Value Per Share-$4.70
Margins
Gross margin is 69.69%, with operating margin of -3.05%, and net profit margin of -6.40%.
Gross Margin69.69%
Operating Margin-3.05%
Pretax Margin-6.28%
Net Profit Margin-6.40%
EBITDA Margin3.77%
EBIT Margin-3.05%
Analyst Forecast
The average price target for Exact Sciences is $105.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$105.00
Price Target Upside1.24% Upside
Analyst ConsensusHold
Analyst Count6
Revenue Growth Forecast14.47%
EPS Growth Forecast-353.69%